In annual filings to state regulators for plan year 2025, some insurers cited increases in utilization of GLP-1 drugs as a contributor to rising premiums
Whether that premium is worth it depends on whether you value the specific additional ingredients enough to pay for them, and on whether you accept that ingredient-level evidence does not guarantee the finished blend works the same way
The most common side effects of these drugs are mild gastrointestinal (GI) issues
In addition, long-term use of GLP-1RAs may also have potential safety risks, such as pancreatitis (Shetty et al., 2022) and thyroid diseases ( 6 Discussion T2DM is a chronic disease characterized by hyperglycemia, which eventually leads to microvascular damage and macrovascular events, as well as complications related to peripheral vascular diseases
This review focuses on Omzo's GLP-1 weight-loss program, which is what the brand's primary advertising positions and what the affiliate link in this article supports
It's not a place to click and hope